Have your own idea? Try our Stock Screener
Chinese (SSE) Biotech Industry Analysis
UpdatedApr 04, 2026
DataAggregated Company Financials
Companies75
- 7D2.1%
- 3M-1.0%
- 1Y-1.0%
- YTDn/a
In the last week, the Biotech industry is up 2.1%, with Sunshine Guojian Pharmaceutical (Shanghai) up 29%. During this same period, the Imeik Technology DevelopmentLtd underperformed, falling 6.3%. Despite this gain, the industry's performance has been flat over the past year. Looking forward, earnings are forecast to grow by 35% annually.
Industry Valuation and Performance
Has the Chinese Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 04 Apr 2026 | CN¥912.0b | CN¥109.9b | CN¥4.7b | 43.5x | 193x | 8.3x |
| Mon, 02 Mar 2026 | CN¥927.5b | CN¥109.3b | CN¥5.9b | 48.3x | 157.2x | 8.5x |
| Wed, 28 Jan 2026 | CN¥990.5b | CN¥106.1b | CN¥3.8b | 51.8x | 262.5x | 9.3x |
| Fri, 26 Dec 2025 | CN¥935.4b | CN¥106.1b | CN¥3.8b | 51.1x | 247.9x | 8.8x |
| Sun, 23 Nov 2025 | CN¥951.5b | CN¥106.1b | CN¥3.8b | 45.4x | 252.2x | 9x |
| Tue, 21 Oct 2025 | CN¥937.2b | CN¥107.6b | CN¥5.0b | 53.2x | 186.9x | 8.7x |
| Thu, 18 Sep 2025 | CN¥989.5b | CN¥107.6b | CN¥5.1b | 49.4x | 193.4x | 9.2x |
| Sat, 16 Aug 2025 | CN¥979.3b | CN¥113.4b | CN¥8.3b | 43.3x | 118x | 8.6x |
| Mon, 14 Jul 2025 | CN¥911.7b | CN¥112.9b | CN¥8.2b | 40.3x | 110.7x | 8.1x |
| Wed, 11 Jun 2025 | CN¥908.1b | CN¥113.0b | CN¥8.3b | 38.1x | 109.6x | 8x |
| Fri, 09 May 2025 | CN¥811.7b | CN¥113.1b | CN¥8.3b | 35.4x | 97.9x | 7.2x |
| Sun, 06 Apr 2025 | CN¥869.7b | CN¥136.1b | CN¥11.7b | 32.8x | 74.6x | 6.4x |
| Tue, 04 Mar 2025 | CN¥843.8b | CN¥136.3b | CN¥11.5b | 33.1x | 73.2x | 6.2x |
| Thu, 30 Jan 2025 | CN¥797.6b | CN¥136.0b | CN¥10.8b | 32.4x | 74.1x | 5.9x |
| Sat, 28 Dec 2024 | CN¥853.4b | CN¥136.0b | CN¥10.8b | 32.7x | 79.3x | 6.3x |
| Mon, 25 Nov 2024 | CN¥893.8b | CN¥141.7b | CN¥11.2b | 35.5x | 79.8x | 6.3x |
| Wed, 23 Oct 2024 | CN¥919.2b | CN¥154.2b | CN¥14.5b | 39.3x | 63.2x | 6x |
| Fri, 20 Sep 2024 | CN¥745.0b | CN¥154.1b | CN¥14.5b | 30.5x | 51.6x | 4.8x |
| Sun, 18 Aug 2024 | CN¥819.7b | CN¥161.2b | CN¥17.3b | 30.9x | 47.5x | 5.1x |
| Tue, 16 Jul 2024 | CN¥824.7b | CN¥161.1b | CN¥17.3b | 32.2x | 47.7x | 5.1x |
| Thu, 13 Jun 2024 | CN¥890.9b | CN¥161.1b | CN¥17.3b | 33.3x | 51.5x | 5.5x |
| Sat, 11 May 2024 | CN¥979.5b | CN¥161.1b | CN¥17.3b | 38.3x | 56.8x | 6.1x |
| Mon, 08 Apr 2024 | CN¥965.0b | CN¥161.0b | CN¥20.1b | 39.9x | 47.9x | 6x |
| Wed, 06 Mar 2024 | CN¥1.0t | CN¥165.5b | CN¥22.0b | 35.5x | 45.8x | 6.1x |
| Fri, 02 Feb 2024 | CN¥880.0b | CN¥167.9b | CN¥21.4b | 31.6x | 41.1x | 5.2x |
| Sun, 31 Dec 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 40.6x | 52.3x | 6.7x |
| Tue, 28 Nov 2023 | CN¥1.1t | CN¥168.1b | CN¥21.5b | 40.7x | 52.5x | 6.7x |
| Thu, 26 Oct 2023 | CN¥1.0t | CN¥169.5b | CN¥23.7b | 38.6x | 42.6x | 6x |
| Sat, 23 Sep 2023 | CN¥1.0t | CN¥170.9b | CN¥25.2b | 39.3x | 41.1x | 6.1x |
| Mon, 21 Aug 2023 | CN¥1.0t | CN¥173.7b | CN¥28.2b | 37.6x | 36.2x | 5.9x |
| Wed, 19 Jul 2023 | CN¥1.1t | CN¥177.4b | CN¥29.9b | 38.4x | 35.5x | 6x |
| Fri, 16 Jun 2023 | CN¥1.1t | CN¥177.4b | CN¥29.3b | 39.3x | 37.2x | 6.1x |
| Sun, 14 May 2023 | CN¥1.1t | CN¥177.7b | CN¥29.6b | 40.7x | 38.8x | 6.5x |
| Tue, 11 Apr 2023 | CN¥1.3t | CN¥186.1b | CN¥36.4b | 43x | 35.1x | 6.9x |
Price to Earnings Ratio
35.1x
Current Industry PE
- Investors are optimistic on the Chinese Biotechnology industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 193x which is higher than its 3-year average PE of 93.7x.
- The 3-year average PS ratio of 6.8x is lower than the industry's current PS ratio of 8.3x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have declined 49% per year over the last three years,
- Revenues have also declined 16% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Comparison
How does Chinese Biotech compare with similar industries?
| CN Market | -2.23% | |
| Healthcare | 2.00% | |
| Biotech | 2.05% | |
| Biotech | 2.05% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 688336 Sunshine Guojian Pharmaceutical (Shanghai) | CN¥92.30 | 29.0% +CN¥12.8b | 237.4% | PE19.4x | |
| 002038 Beijing SL Pharmaceutical | CN¥8.98 | 35.9% +CN¥2.4b | 30.7% | PE110.1x | |
| 300204 Staidson (Beijing) BioPharmaceuticals | CN¥31.52 | 13.5% +CN¥1.8b | 318.0% | PS61.6x | |
| 688382 InventisBio | CN¥22.80 | 14.1% +CN¥1.6b | 16.3% | PS353.3x | |
| 002675 Yantai Dongcheng Pharmaceutical GroupLtd | CN¥14.58 | 10.8% +CN¥1.2b | 7.8% | PE61.5x |